keyboard_arrow_up

Regenerative Medicine Market in the US 2014-2018

Regenerative Medicine Market in the US 2014-2018  is a new market research publication announced by Reportstack. Regenerative medicine is the branch of medicine which uses therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. This branch of medicine focuses on repairing, replacing, or regenerating the damaged cells of the body and thus represents a paradigm shift in healthcare treatment. The two main technologies used in regenerative medicine are tissue engineering and stem cell technology.

The analysts forecast the Regenerative Medicine market in the US will grow at a CAGR of 19.88 percent over the period 2013-2018.The Regenerative Medicine market in the US can be divided into 11 segments: Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Cardiology, Plastic and Reconstructive Surgery, Osteoarthritis, Trauma, General Surgery, Hernia Repair, Burns, Urology, and Urogynecology.

This report  has been prepared based on an in-depth market analysis with inputs from industry experts. It focuses on the Regenerative Medicine market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Country

US
Key Vendors

IBM Corp.
Oracle Corp.
SAP AG
SAS Institute Inc.

Other Prominent Vendors 

Aastrom Biosciences Inc.
Acologix Inc.
Advanced Cell Technology Inc.
Arteriocyte Inc.
Athersys Inc.
Avita Medical Ltd.
Bacterin International Inc.
Bellicum Pharmaceuticals Inc.
Bioactive Regenerative Therapeutics Inc.
BioCardia Inc.
BioLife Solutions Inc.
CryoLife Inc.
Cynata Therapeutics Inc.
Cytomedix Inc.
Cytori Therapeutics Inc.
Fibrocell Science Inc.
Forticell Bioscience Inc.
GE Healthcare
Geron Corp.
Histogenics
Humacyte Inc.
Integra Life Sciences Holdings Corp.
InVivo Therapeutics
Kensey Nash Corp.
Kinetic Concepts Inc.
MaxCyte Inc.
Mesoblast Ltd.
Nanofiber Solutions CTO
NeoStem Inc.
Neuralstem Inc.
Olympus Terumo Biomaterials Corp.
Opexa Therapeutics Inc.
Organogenesis Inc.
Osiris Therapeutics Inc.
Osteotech Inc.
Pluristem Therapeutics Inc.
ReNeuron Group plc
RTI Biologics Inc.
SanBio Inc.
StemCells Inc.
Tengion Inc.
Thermo Fischer Scientific Inc.
Tissue Genesis Inc.
ViaCyte Inc. 
Key Market Driver

Increasing Prevalence of Degenerative Diseases
For a full, detailed list, view our report.
Key Market Challenge

Stringent Regulatory Approval Process
For a full, detailed list, view our report.
Key Market Trend

Increase in Mergers and Acquisitions
For a full, detailed list, view our report.
Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

To view the table of contents and know more details please visit Regenerative Medicine Market in the US 2014-2018.